封面
市场调查报告书
商品编码
1878102

全球阻塞设备市场-2025年至2030年预测

Global Occlusion Devices Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球阻塞设备市场预计将从 2025 年的 33.83 亿美元成长到 2030 年的 44.23 亿美元,复合年增长率为 5.51%。

阻塞是指血管或其他器官的阻塞或闭塞,这是一项重大的临床挑战,需要使用专门的医疗技术来解决。阻塞设备在清除此类阻塞、恢復血流或辅助微创手术方面发挥关键作用。这些装置对于治疗多种疾病至关重要,包括心血管疾病、妇科疾病和神经系统疾病。由于全球医疗保健环境的多种因素,预计这些装置的市场将呈现强劲成长。

主要市场成长驱动因素

全球阻塞设备市场的扩张主要受患者数量成长的驱动。这一增长与需要解除血管闭塞的各种疾病(尤其是心血管和神经系统疾病)的盛行率上升直接相关。随着这些疾病在全球范围内负担加重,对有效介入治疗方法的临床需求也随之增加。

推动市场成长的关键趋势之一是全球微创手术的日益普及。这些手术通常使用血管闭塞装置,与传统开放性手术相比,能为患者带来显着优势,例如创伤更小、住院时间更短、恢復更快。手术方式的转变是推动先进血管闭塞技术应用的主要因素。此外,针对这些微创手术的有利报销政策的建立和完善,提高了患者获得治疗的机会,从而显着促进了市场成长。临床疗效、患者对微创治疗的需求以及有利的支付框架共同构成了血管闭塞装置市场强劲的成长引擎。

市场限制

儘管市场呈现成长态势,但仍存在诸多限制限制其扩张。其中一个关键挑战是医疗设备认证的严格监管环境。获得阻塞设备的市场核准通常十分复杂、耗时且成本高昂,需要大量的临床数据来证明其安全性和有效性。这种严格的核准途径导致产品上市延迟,并增加了製造商的研发成本。

进一步加剧这项挑战的是,熟练这些先进设备操作技能的专业人员普遍短缺。有效部署血管闭塞装置通常需要专门训练和进阶操作技能。由于合格操作人员的配备是使用这些先进医疗设备的先决条件,因此,熟练临床医生的短缺可能会限制新技术的普及率并抑制市场成长。

调查方法与市场情报框架

本分析全面检验了目前闭塞装置的市场格局,分析了与需求、供应、销售和近期产业发展相关的趋势。报告旨在透过识别和评估影响产业发展轨蹟的关键驱动因素、阻碍因素和机会,全面整体情况市场环境。

本研究的关键组成部分是对法规环境和区域格局的详细分析,包括对各地区行业动态、趋势以及现行政策法规的深入审查。了解这个全面的法规结构对相关人员至关重要,因为它能提供对产业产生重大影响的因素(例如合规要求和市场准入障碍)的关键洞察。

透过广泛的二手资料研究,我们评估了竞争格局,以确定主要行业参与者并评估其对整体市场及相关细分市场的收入贡献。资讯收集过程利用了多种来源,例如产业协会发布的各类调查和数据、分析师报告、企业投资者报告、资讯来源、学术期刊等。

我们的市场规模调查方法采用严谨的两阶段流程。我们同时运用自下而上和自上而下的分析方法来评估整体市场及其关键细分市场的规模。然后,我们将这些计算得出的数据与全球封堵器价值链中主要相关人员的原始数据进行比对,以确保其与实际市场情况相符。

我们分析的最后阶段是全面的市场工程,这包括将来自不同资讯来源的资料与现有的专有资料集进行整合。为了确保准确性和可靠性,我们对市场区隔和预测都采用了多种资料三角验证技术,从而得出稳健且检验的市场展望。

我们透过详细的分析、图表和图形来呈现市场讯息,旨在帮助我们的客户更快、更有效地了解全球闭塞装置市场,并帮助他们根据清晰、易于获取的数据做出战略决策。

市场格局由几家成熟的医疗技术领导企业主导。本次全面的市场分析重点介绍了Terumo Corporation NV)、雅培 (Abbott) 和美Medtronic)等主要企业。了解这些公司的策略、产品系列和市场地位对于理解阻塞设备产业的竞争动态和未来发展方向至关重要。这些成熟企业的存在凸显了市场的成熟度,以及为满足不断变化的临床需求和应对复杂的法规环境而持续创新的必要性。

本报告的主要优势:

  • 深入分析:获得主要和新兴地区的深入市场洞察,重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局:了解全球主要企业的策略倡议,并了解透过正确的策略进入市场的可能性。
  • 市场驱动因素与未来趋势:探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议:利用这些见解,在快速变化的环境中製定策略决策,发展新的商业机会和收入来源。
  • 受众广泛:适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业,且经济实惠。

企业使用我们的报告的目的是什么?

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围:

  • 2022年至2024年的历史数据和2025年至2030年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入成长和预测评估,包括国家/地区
  • 公司概况(策略、产品、财务资讯、关键发展等)

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围

第二章 4. 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 全球阻塞设备市场(依类型划分)

  • 介绍
  • 堵塞清除剂
  • 栓塞治疗装置
  • 输卵管阻塞设备

6. 全球阻塞设备市场(依应用划分)

  • 介绍
  • 心臟病学
  • 妇科
  • 神经病学
  • 泌尿系统
  • 其他的

7. 全球阻塞设备市场(依最终用户划分)

  • 介绍
  • 医院
  • 门诊手术中心

8. 全球阻塞设备市场(依地区划分)

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章:竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章:公司简介

  • Abbott
  • Penumbra, Inc.
  • Medtronic
  • AtriCure, Inc.
  • Terumo Europe NV
  • Neuravi
  • Prytime Medical Devices, Inc
  • Acrostak Int.
  • ArtVentive Medical Group, Inc.
  • EndoShape, Inc

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611891

The global occlusion devices market is projected to rise at a 5.51% CAGR, achieving USD 4.423 billion in 2030 from USD 3.383 billion in 2025.

Occlusion, defined as the blockage or closure of a blood vessel or other bodily organ, represents a significant clinical challenge addressed by specialized medical technology. Occlusion devices are instrumental in removing such blockages to restore blood flow or facilitate minimally invasive surgical procedures. These devices are critical in treating a range of conditions, including cardiovascular, gynecological, and neurological defects. The market for these devices is projected to demonstrate robust growth, driven by several converging factors within the global healthcare landscape.

Primary Market Growth Drivers

The expansion of the occlusion devices market is largely attributable to a growing patient population worldwide. This increase is directly linked to the rising prevalence of various disorders that necessitate occlusion removal, particularly in the cardiovascular and neurological domains. As the global burden of these diseases increases, so does the clinical demand for effective interventional solutions.

A pivotal trend accelerating market growth is the rising global adoption of minimally invasive surgeries. These procedures, which often utilize occlusion devices, offer significant patient benefits over traditional open surgery, including reduced trauma, shorter hospital stays, and faster recovery times. This shift in surgical preference is a major driver for the adoption of advanced occlusion technologies. Furthermore, the establishment and evolution of favorable reimbursement policies for such minimally invasive procedures are making these treatments more accessible to patients, thereby providing a substantial boost to the market. The combination of clinical efficacy, patient demand for less invasive options, and supportive payment frameworks creates a powerful growth engine for the occlusion devices sector.

Market Restraints

Despite the positive growth trajectory, the market faces notable constraints that could temper its expansion. A significant challenge is the stringent regulatory environment governing the approval of medical devices. The process for gaining market authorization for occlusion devices is often complex, time-consuming, and costly, requiring extensive clinical data to demonstrate safety and efficacy. This rigorous pathway can delay product launches and increase development expenses for manufacturers.

Compounding this challenge is a widespread lack of trained and skilled professionals proficient in the use of these advanced devices. The effective deployment of occlusion devices often requires specialized training and a high degree of procedural expertise. A shortage of such skilled clinicians can limit the adoption rate of new technologies and restrain market growth, as the availability of qualified operators is a prerequisite for the utilization of these sophisticated medical tools.

Research Methodology and Market Intelligence Framework

This analysis provides a comprehensive examination of the current occlusion devices market landscape, scrutinizing trends related to demand, supply, sales, and recent industry developments. The report is structured to deliver an exhaustive picture of the market environment by identifying and evaluating the major drivers, restraints, and opportunities that are influencing the industry's trajectory.

A critical component of the study involves a detailed analysis of the regulatory and regional landscape. This encompasses an in-depth review of industry developments, trends, and the specific policies and regulations implemented across various geographical regions. Understanding this overarching regulatory framework is essential for stakeholders, as it provides critical insight into the compliance requirements and market entry barriers that significantly impact the industry.

The competitive landscape has been assessed through extensive secondary research designed to identify key industry players and evaluate their revenue contribution to the overall market and relevant segments. This intelligence-gathering process incorporates a wide array of sources, including various studies and data published by industry associations, analyst reports, company investor presentations, press releases, and academic journals.

The methodology for determining market size employs a rigorous, dual-pronged approach. Both bottom-up and top-down analytical techniques are utilized to calculate the size of the overall market and its key segments. The values derived from these calculations are subsequently correlated with primary inputs obtained from key stakeholders operating across the global occlusion devices value chain, ensuring alignment with real-world market conditions.

The final phase of the analysis involves comprehensive market engineering. This process integrates data from diverse sources and existing proprietary datasets. To ensure accuracy and reliability, various data triangulation methods are applied for both market breakdown and forecasting, resulting in a robust and validated market outlook.

The resulting market intelligence is presented through detailed analysis, charts, and graphics. This format is designed to facilitate a faster and more efficient understanding of the global occlusion devices market for clients, enabling strategic decision-making based on clear, accessible data.

The market landscape features several established medical technology leaders. Major players profiled as part of the comprehensive market analysis include Terumo Europe NV, Abbott, and Medtronic, among others. The strategies, product portfolios, and market positions of these companies are integral to understanding the competitive dynamics and future direction of the occlusion devices industry. The presence of such well-established participants underscores the market's maturity and the continuous innovation required to meet evolving clinical needs and navigate the complex regulatory environment.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

  • GLOBAL OCCLUSION DEVICES MARKET BY TYPE
  • Occlusion Removal Devices
  • Embolization Devices
  • Tubal Occlusion Devices
  • GLOBAL OCCLUSION DEVICES MARKET BY APPLICATION
  • Cardiology
  • Gynaecology
  • Neurology
  • Urology
  • Others
  • GLOBAL OCCLUSION DEVICES MARKET BY END-USERS
  • Hospitals
  • Ambulatory SurgIcal Centers
  • GLOBAL OCCLUSION DEVICES MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL OCCLUSION DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Occlusion Removal Devices
  • 5.3. Embolization Devices
  • 5.4. Tubal Occlusion Devices

6. GLOBAL OCCLUSION DEVICES MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cardiology
  • 6.3. Gynaecology
  • 6.4. Neurology
  • 6.5. Urology
  • 6.6. Others

7. GLOBAL OCCLUSION DEVICES MARKET BY END-USERS

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory SurgIcal Centers

8. GLOBAL OCCLUSION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott
  • 10.2. Penumbra, Inc.
  • 10.3. Medtronic
  • 10.4. AtriCure, Inc.
  • 10.5. Terumo Europe NV
  • 10.6. Neuravi
  • 10.7. Prytime Medical Devices, Inc
  • 10.8. Acrostak Int.
  • 10.9. ArtVentive Medical Group, Inc.
  • 10.10. EndoShape, Inc

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations